Phibro Animal Health, a leading manufacturer of pharmaceutical and nutrition products for livestock, raised $176 million by offering 11.8 million shares at $15, below the range of $16 to $18. Phibro Animal Health plans to list on the NASDAQ under the symbol PAHC. Phibro Animal Health initially filed confidentially on 1/13/2014. BofA Merrill Lynch, Morgan Stanley and Barclays acted as lead managers on the deal.
